Jump Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Jump Financial’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,284	Closed	-$35K	–	2147
2022 Q3	$35K	Buy	+22,284	New	+$50.5K	﹤0.01%	1507
2021 Q2	–	Sell	-245,472	Closed	-$2.03M	–	1490
2021 Q1	$2.03M	Buy	+245,472	New	+$2.59M	0.19%	95

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jump Financial's SRNE Position: Q4 2022 in Review

Jump Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 22,284 shares — an estimated $35K sold.

Jump Financial first reported a position in SRNE in Q1 2021 and held it in 2 quarters. The position peaked at $2.03M in Q1 2021. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Jump Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Jump Financial sold 22,284 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $35K.
Jump Financial first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 2 quarters.
Jump Financial's Sorrento Therapeutics, Inc. position peaked at $2.03M in Q1 2021.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Jump Financial's 13F filing for Q4 2022, filed 14 Feb 2023.